
NGM Biopharmaceuticals (NGM) Reports Q3 Loss, Lags Revenue Estimates
Published on November 4, 2021
NGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of 2.63% and -1.74%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the...
